1. Home
  2. / Job Openings
  3. / With Billion-Dollar Investment, Swiss Multinational Will Create 12,000 Jobs in the U.S. In Factories, Technology, and Business Operations
Reading time 4 min of reading Comments 0 comments

With Billion-Dollar Investment, Swiss Multinational Will Create 12,000 Jobs in the U.S. In Factories, Technology, and Business Operations

Written by Valdemar Medeiros
Published on 24/04/2025 at 00:34
Updated on 24/04/2025 at 00:35
Com investimento bilionário, multinacional suíça vai gerar 12 mil empregos nos EUA em fábricas, tecnologia e operações comerciais
Foto: IA
  • Reaction
1 person reacted to this.
React to this article

Swiss Multinational Creates Jobs in the USA with Billion-Dollar Investment from Roche; There Are 12,000 Openings in Health, Technology, and Operations — See How to Work in the United States with a Visa.

The Swiss multinational Roche announced a new investment plan in the United States that aims to create more than 12,000 jobs in various sectors over the next five years. With an investment of US$ 50 billion, the company will expand its activities in research, development, manufacturing, and distribution of medicines and diagnostics, consolidating its presence in several U.S. states. The announcement, made through an official company statement, reinforces Roche’s expansion strategy in the world’s largest healthcare market. The Swiss multinational creates jobs in the USA and promises to expand its workforce, which already exceeds 25,000 employees, with a focus on opportunities in Indiana, Pennsylvania, California, Massachusetts, New Jersey, Kentucky, and Oregon.

Roche Invests US$ 50 Billion and Expands Units in the USA

The billion-dollar investment from Roche in the USA will be allocated between building new manufacturing units and research centers, as well as modernizing existing infrastructures. A total of 13 new industrial and technological projects are planned, including the installation of:

  • A P&D Center in Massachusetts focused on research with artificial intelligence, cardiovascular issues, and metabolic diseases;
  • A new state-of-the-art gene therapy manufacturing plant in Pennsylvania;
  • A factory focused on continuous glucose monitoring in Indiana;
  • A production center with over 84,000 m² for innovative obesity medicines;
  • Significant expansions at Roche’s existing facilities in Arizona, Indiana, New Jersey, and California.

The multinational reported that these measures aim to strengthen its capacity to meet the demand for rapid diagnostics, advanced therapies, and personalized medicines in U.S. territory.

More Than 12,000 Jobs Will Be Generated Directly and Indirectly

According to Roche’s statement, the more than 12,000 new job openings will be distributed as follows:

  • 1,000 direct positions in the new factories, laboratories, and logistics units of the company;
  • 6,500 jobs in construction to support the ongoing projects;
  • 4,500 indirect positions in areas such as technical support, supply chain, transportation, and services.

The company also stated that there will be opportunities at different qualification levels, from production line workers to researchers with PhDs, data analysts, engineers, and IT specialists.

Swiss Multinational Creates Jobs in the USA with a Focus on Health Innovation

Headquartered in Basel, Roche is one of the largest companies in the pharmaceutical and diagnostics sector worldwide, with a presence in over 100 countries. In the United States, the group already operates 24 operational units in eight states, in addition to distribution and innovation centers focused on genetic research and oncology.

The new investment cycle is part of the company’s strategy to increase the capacity to deliver innovative medicines, especially in rapidly growing areas such as oncology, metabolic diseases, digital health, and artificial intelligence applied to medicine.

With this announcement, Roche joins the list of multinationals that reinforce investments in the USA as a way to strengthen local production, reduce dependence on global supply chains, and accelerate access to modern treatments for the population.

How to Apply for Jobs at Roche United States

Brazilian professionals who dream of working abroad can benefit from this expansion. Roche allows international applications and frequently hires qualified foreigners to join its global team. To apply for positions at Roche in the United States, you need to:

  1. Access Roche’s career portal: careers.roche.com
  2. Select the country “United States”;
  3. Filter by areas of interest (research, production, IT, logistics, etc.);
  4. Carefully read the requirements for each position, such as education, experience, and language proficiency;
  5. Submit your resume in English and fill out the data in the online form.

It is important to pay attention to work visa requirements. In many cases, Roche supports the H-1B visa process for qualified professionals. The company may also offer relocation packages, depending on the role and urgency of the hiring.

Jobs in the USA: Health and Technology Lead Demand for Foreigners

Roche’s decision to expand its operations in the United States comes at a time of labor shortages in the country, especially in the fields of science, engineering, health, and technology. It is estimated that, by 2030, the U.S. healthcare sector will need to fill more than 2 million new positions to meet the growing demand for specialized services.

As a result, multinationals operating in the biotechnology and diagnostics field — like Roche — have increased hiring and facilitated access for foreigners to opportunities in the USA, either through partnerships with universities or through exchange programs or direct hiring of talents with international experience.

Investments Reinforce Roche’s Presence as a Global Reference

With this new cycle of investments, Roche reinforces its position as a leader in pharmaceutical and diagnostic solutions, focusing on innovation, technology, and sustainable production. The expansion of facilities in the USA aims to reduce delivery times, improve logistics, and make patient care more agile, especially for high-cost treatments.

The Swiss multinational also reaffirms its commitment to sustainability and social impact, ensuring that the new centers will be built with green technology, efficient energy use, and zero emission targets by 2050.

Sign up
Notify of
guest
0 Comments
most recent
older Most voted
Built-in feedback
View all comments
Valdemar Medeiros

Graduated in Journalism and Marketing, he is the author of over 20,000 articles that have reached millions of readers in Brazil and abroad. He has written for brands and media outlets such as 99, Natura, O Boticário, CPG – Click Petróleo e Gás, Agência Raccon, among others. A specialist in the Automotive Industry, Technology, Careers (employability and courses), Economy, and other topics. For contact and editorial suggestions: valdemarmedeiros4@gmail.com. We do not accept resumes!

Share in apps
0
I'd love to hear your opinion, please comment.x